Cisplatin Decreases ENaC Activity Contributing to Renal Salt Wasting Syndrome

Cisplatin (CDDP) is an important anticancer drug. A common side effect of CDDP is renal salt and water-wasting syndrome (RSWS). The origin of RSWS is obscure. Emerging evidence, though, suggests that broad inhibition of sodium transport proteins by CDDP may result in decreases in tubular reabsorptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Antonio G., Mironova, Elena, Archer, Crystal R., Contreras, Jorge, Stockand, James D., Abd El-Aziz, Tarek Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464492/
https://www.ncbi.nlm.nih.gov/pubmed/32752278
http://dx.doi.org/10.3390/cancers12082140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464492/
https://www.ncbi.nlm.nih.gov/pubmed/32752278
http://dx.doi.org/10.3390/cancers12082140

Ejemplares similares